4.34
price up icon0.23%   0.010
after-market 시간 외 거래: 4.34
loading
전일 마감가:
$4.33
열려 있는:
$4.37
하루 거래량:
111.66K
Relative Volume:
0.56
시가총액:
$162.79M
수익:
$147.12M
순이익/손실:
$-33.88M
주가수익비율:
-9.0323
EPS:
-0.4805
순현금흐름:
$-13.62M
1주 성능:
-7.46%
1개월 성능:
-16.05%
6개월 성능:
-49.94%
1년 성능:
-41.59%
1일 변동 폭
Value
$4.26
$4.45
1주일 범위
Value
$4.26
$4.77
52주 변동 폭
Value
$3.625
$8.9799

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Name
명칭
Lifecore Biomedical Inc
Name
전화
(952) 368-4300
Name
주소
3515 LYMAN BOULEVARD, CHASKA
Name
직원
382
Name
트위터
Name
다음 수익 날짜
2026-05-06
Name
최신 SEC 제출 서류
Name
LFCR's Discussions on Twitter

Compare LFCR vs TAK, HLN, TEVA, ZTS, UTHR

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
LFCR icon
LFCR
Lifecore Biomedical Inc
4.34 162.42M 147.12M -33.88M -13.62M -0.4805
TAK icon
TAK
Takeda Pharmaceutical Co Adr
17.44 55.06B 29.91B 1.30B 3.49B 0.4056
HLN icon
HLN
Haleon Plc Adr
9.94 43.07B 14.54B 2.22B 2.58B 0.4871
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
31.08 35.88B 17.53B 1.58B 444.18M 1.3457
ZTS icon
ZTS
Zoetis Inc
76.92 31.59B 9.51B 2.64B 2.14B 6.0361
UTHR icon
UTHR
United Therapeutics Corp
527.94 26.32B 3.17B 1.29B 1.01B 27.09

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2026-03-17 업그레이드 Barrington Research Mkt Perform → Outperform
2025-09-04 개시 KeyBanc Capital Markets Sector Weight
2025-05-21 개시 William Blair Outperform
2024-09-05 개시 Craig Hallum Buy
2024-08-28 다운그레이드 Barrington Research Outperform → Mkt Perform
2023-03-20 다운그레이드 Stephens Overweight → Equal-Weight
모두보기

Lifecore Biomedical Inc 주식(LFCR)의 최신 뉴스

pulisher
05:34 AM

Lifecore Biomedical Inc (LFCR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

05:34 AM
pulisher
05:32 AM

Lifecore Biomedical Inc (LFCR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

05:32 AM
pulisher
Jul 26, 2026

LFCR|Lifecore Biomedical Inc|Price:4.330|Chg%:-0.100 - TradingKey

Jul 26, 2026
pulisher
Jul 25, 2026

Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical - The National Law Review

Jul 25, 2026
pulisher
Jul 25, 2026

Lifecore Biomedical, Inc. Revenue Breakdown – NASDAQ:LFCR - TradingView

Jul 25, 2026
pulisher
Jul 24, 2026

Lifecore Biomedical Inc. (LFCR) Q1 2026 Earnings: EPS Misses Estimates by Wide Margin Amid Operational ChallengesBook Value Growth - dars.gov.et

Jul 24, 2026
pulisher
Jul 24, 2026

Lifecore Biomedical Inc (LFCR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 24, 2026
pulisher
Jul 22, 2026

Lifecore Biomedical (LFCR) Q1 2026 earnings summary - Quartr

Jul 22, 2026
pulisher
Jul 22, 2026

Lifecore Biomedical (LFCR) Proxy filing Summary - Quartr

Jul 22, 2026
pulisher
Jul 20, 2026

LFCR Deadline: LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Securities Fraud Lawsuit - GuruFocus

Jul 20, 2026
pulisher
Jul 16, 2026

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Sahm

Jul 16, 2026
pulisher
Jul 16, 2026

What Triggered Lifecore Biomedical's Recent Stock Plunge - Kavout | AI

Jul 16, 2026
pulisher
Jul 15, 2026

New Lifecore Hire Gets 3,500 Stock Units Vesting in Three Years - Stock Titan

Jul 15, 2026
pulisher
Jul 15, 2026

Lifecore Biomedical Inc (LFCR) Continues Winning Contracts, Ignored by the Market - Yahoo Finance

Jul 15, 2026
pulisher
Jul 14, 2026

Lifecore Biomedical (LFCR) AGM 2026 Summary - Quartr

Jul 14, 2026
pulisher
Jul 14, 2026

Lifecore Biomedical (LFCR) Q2 2024 earnings summary - Quartr

Jul 14, 2026
pulisher
Jul 13, 2026

Lifecore Biomedical (LFCR) Q3 2024 earnings summary - Quartr

Jul 13, 2026
pulisher
Jul 13, 2026

Lifecore Biomedical Inc. (LFCR) Q1 2026 Earnings: Deep EPS Miss Highlights Operational DifficultiesFull Year Guidance - dars.gov.et

Jul 13, 2026
pulisher
Jul 09, 2026

Lifecore Biomedical (LFCR) Gains 3.17% as Stock Tests Key Resistance at $4.95FRAMA Signal - dars.gov.et

Jul 09, 2026
pulisher
Jul 08, 2026

Lifecore Biomedical Inc. (LFCR) Drops Nearly 6% as Stock Tests Key Support LevelsFloat Adjusted Cap - dars.gov.et

Jul 08, 2026
pulisher
Jul 07, 2026

Lifecore Biomedical (LFCR) Slips 3.17%: Testing Key Support at $4.65WMA Signal - dars.gov.et

Jul 07, 2026
pulisher
Jul 07, 2026

LFCR Q1 2026 Earnings: EPS Misses Estimates Amid Operational ChallengesGross Profit Margin - dars.gov.et

Jul 07, 2026
pulisher
Jul 06, 2026

LFCR Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Revenue Not DisclosedEarnings Risk Report - DonanımHaber

Jul 06, 2026
pulisher
Jul 06, 2026

Craig-Hallum Maintains Lifecore Biomedical(LFCR.US) With Buy Rating - Moomoo

Jul 06, 2026
pulisher
Jul 04, 2026

Lifecore Biomedical (LFCR) Stock Forum and Discussion - Moomoo

Jul 04, 2026
pulisher
Jul 02, 2026

Form 13D/A LIFECORE BIOMEDICAL For: 2 July By Investing.com - Investing.com India

Jul 02, 2026
pulisher
Jul 02, 2026

Form 13D/A Lifecore Biomedical For: 2 July By Investing.com - Investing.com Nigeria

Jul 02, 2026
pulisher
Jul 02, 2026

Lifecore Biomedical faces $52.1M Series A preferred redemption due Dec. 28, 2026 - TradingView

Jul 02, 2026
pulisher
Jul 02, 2026

Lifecore Biomedical (NASDAQ: LFCR) gets $52.1M preferred redemption requests - Stock Titan

Jul 02, 2026
pulisher
Jul 02, 2026

[SCHEDULE 13D/A] LIFECORE BIOMEDICAL, INC. \DE\ Amended Major Shareholder Report - Stock Titan

Jul 02, 2026
pulisher
Jul 02, 2026

(LFCR) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Jul 02, 2026
pulisher
Jun 30, 2026

Lifecore Biomedical’s New Collaborations May Strengthen Long-Term Value ProspectsDownward Estimate Revision - dars.gov.et

Jun 30, 2026
pulisher
Jun 30, 2026

Can Lifecore Biomedical, Inc. (LFCR) Unlock Long-Term Value Through Expanding Biopharma Collaborations? - Yahoo Finance

Jun 30, 2026
pulisher
Jun 30, 2026

Is Now An Opportune Moment To Examine Lifecore Biomedical, Inc. (NASDAQ:LFCR)? - simplywall.st

Jun 30, 2026
pulisher
Jun 28, 2026

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirt - The National Law Review

Jun 28, 2026
pulisher
Jun 28, 2026

12 Best Low-Priced Pharma Stocks to Buy Right Now - Insider Monkey

Jun 28, 2026
pulisher
Jun 28, 2026

Enterprise value to revenue forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView

Jun 28, 2026
pulisher
Jun 28, 2026

Price to sales forward of Lifecore Biomedical, Inc. – SWB:LDE - TradingView

Jun 28, 2026
pulisher
Jun 27, 2026

Price to book forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Price to sales forward of Lifecore Biomedical, Inc. – LSX:899376 - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Lifecore Biomedical, Inc. Actuals & Estimates (NASDAQ:LFCR) - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review

Jun 27, 2026
pulisher
Jun 27, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biom - The National Law Review

Jun 27, 2026
pulisher
Jun 27, 2026

Enterprise value to EBITDA forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Enterprise value to EBITDA forward of Lifecore Biomedical, Inc. – LSX:899376 - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Enterprise value to EBIT forward of Lifecore Biomedical, Inc. – NASDAQ:LFCR - TradingView

Jun 27, 2026
pulisher
Jun 27, 2026

Price to earnings forward of Lifecore Biomedical, Inc. – LSX:899376 - TradingView

Jun 27, 2026
pulisher
Jun 26, 2026

Lifecore Biomedical, Inc. Actuals & Estimates (GETTEX:LDE) - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Lifecore Biomedical, Inc. Actuals & Estimates (BOATS:LFCR) - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

LFCR Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

LDE Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Lifecore Biomedical Inc (LFCR) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$52.73
price down icon 0.30%
RDY RDY
$11.77
price down icon 0.17%
$25.41
price up icon 2.01%
$176.41
price up icon 0.36%
$17.64
price up icon 2.29%
$527.94
price down icon 0.10%
자본화:     |  볼륨(24시간):